Enlaza Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Enlaza Therapeutics's estimated annual revenue is currently $4.3M per year.
- Enlaza Therapeutics's estimated revenue per employee is $78,935
Employee Data
- Enlaza Therapeutics has 54 Employees.
- Enlaza Therapeutics grew their employee count by 32% last year.
Enlaza Therapeutics's People
| Name | Title | Email/Phone |
|---|
Enlaza Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is Enlaza Therapeutics?
Enlaza Therapeutics is pioneering the field of covalent biologics.These novel classes of protein therapeutics deliver more efficacious and safer treatments for patients. The company’s proprietary War-LockTM platform leverages leading synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza is building a pipeline of first-in-class covalent biologics.
keywords:N/A
N/A
Total Funding
54
Number of Employees
$4.3M
Revenue (est)
32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.5M | 54 | 4% | N/A |
#2 | $4.2M | 54 | 10% | $376.5M |
#3 | $15M | 54 | N/A | N/A |
#4 | $13.1M | 54 | -32% | N/A |
#5 | $5.3M | 54 | 29% | N/A |